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When Mackenzie ‘Mack’ Walser died late last year, nephrology lost one of its most creative investigators. He was a critical and unorthodox 
thinker who tackled diﬃcult clinical and physi-
ological problems with answers that invariably 
added new insights to the ﬁeld. Indeed, ‘creative’ 
does characterize Mack Walser’s research, because 
he developed methods to identify mechanisms 
underlying complex questions about kidney func-
tion and introduced scientiﬁcally based methods 
for treating patients with chronic kidney disease 
(CKD). His reports are easily identiﬁed by his 
careful deﬁnition of the problem being studied 
and the thoroughness of his investigative tech-
niques. Mack Walser was a very careful experi-
mentalist who often devised new mathematical 
models. He was also very generous with his time 
and scientific knowledge. His willingness to 
share ideas and develop scientiﬁc approaches was 
instrumental in the development of the academic 
careers of young investigators in the United States 
and around the world. Certainly, I learned a great 
deal from him.
Walser graduated from Columbia University’s 
College of Physicians and Surgeons and com-
pleted his medical residency at Massachusetts 
General Hospital. He then began a postdoctoral 
training with Donald Seldin at the University of 
Texas Southwestern, where he later joined the fac-
ulty. During the two years he spent in the Naval 
Reserve and subsequent years at the National 
Institutes of Health, Walser published classic 
papers of clinical research in which he deﬁned 
the precision of measuring insulin clearance in 
adults, and devised methods for estimating body 
ﬂuid spaces. In 1957, he was recruited to join the 
Johns Hopkins faculty in the Department of Phar-
macology and Experimental Therapeutics, where 
he remained until his retirement.
In his early years, Walser was keenly interested 
in investigating the processes of active and pas-
sive mechanisms in the kidney that regulate the 
transport of inorganic ions. In multiple reports 
from 1959 through the early 1970s, Walser dem-
onstrated how ion pairs and charged inorganic 
ions are transported by the kidney tubule.1–6 His 
studies of interactions between sulfates and cal-
cium or strontium demonstrated that the excre-
tion of these cations rose sharply in proportion to 
the excretion of sulfates. In these same studies, he 
showed that the induction of natriuresis increased 
the renal excretion of calcium, providing the basis 
for current methods of treating hypercalcemia. 
During this period, Walser enlarged the scope of 
his experiments by studying transport properties 
in isolated membranes from epithelial tissues, 
including investigations of the transport of dif-
ferent ions following biochemical inhibition of 
Na/K-ATPase.
His formidable abilities to combine theoreti-
cal thinking with physiological insight are best 
exempliﬁed by his development of the concept 
of disequilibrium pH. At that time, much con-
troversy existed regarding the mechanism of 
urinary acidiﬁcation. Walser developed the idea 
that a simple measurement of pH in the tubular 
lumen compared with the same ﬂuid equilibrated 
with known pCO2 could distinguish between the 
two, a procedure that was used by Rector and his 
group to solve the problem in favor of H+ secre-
tion rather than HCO3 reabsorption.
7
One of Walser’s long-standing interests was 
to understand how body fluid compartments 
varied. His early studies of inulin and bromide 
spaces led him to develop methods for measuring 
total body water by analyzing the volume of dis-
tribution of isotopically labeled urea. Character-
istically, he enlarged the scope of his studies and 
used the same technique to examine how urea 
is metabolized. In a classic clinical investigation, 
he demonstrated that urea derived from amino 
acid metabolism is in fact metabolized but that 
the nitrogen released during urea breakdown is 
recycled to form more urea. This led him to the 
conclusion that the long-standing paradigm that 
urea nitrogen was nutritionally important was, in 
fact, incorrect.8–10 I was fortunate to work with 
him in clinical investigations which demonstrated 
that nitrogen from urea has little or no inﬂuence 
on amino acid metabolism.11,12 In following up 
on these experiments about urea metabolism in 
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patients with CKD, Walser provided critical basic 
information about the nitrogen requirements of 
patients with CKD and demonstrated that admin-
istration of nitrogen-free analogues of essential 
amino acids (ketoacids) to patients with CKD 
would not only reduce the accumulation of urea 
and other nitrogen-containing waste products but 
could also be used to improve the patients’ nitro-
gen balance and, hence, protein stores.9,13 These 
few references only touch the surface of Walser’s 
contributions to science but demonstrate his com-
mitment to clinical investigations.
For much of his remaining career, Walser cham-
pioned the use of dietary methods for treating 
patients with CKD or other diseases such as liver 
disease or errors of the urea cycle that are char-
acterized by protein intolerance. Scientiﬁcally, he 
provided numerous insights into the diﬃcult meta-
bolic problems encountered by these patients. He 
also championed treatments for problems of CKD 
patients in three books, which outline how patients 
can avoid complications of kidney disease.14
In addition to his scientiﬁc interests, Walser 
greatly enjoyed tennis and sailing. He was a lib-
eral Democrat and ‘practiced what he preached.’ 
Most of all, however, he was a scholar. The disci-
pline of nephrology, patients with kidney disease, 
and his many friends greatly beneﬁted from his 
wisdom and his commitment to improving the 
lives of patients.
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